NSAM
North Star Asset Management Portfolio holdings
AUM
$2.36B
1-Year Return
14.42%
This Quarter Return
-6.89%
1 Year Return
+14.42%
3 Year Return
+63.82%
5 Year Return
+104.72%
10 Year Return
+249.93%
AUM
$1.81B
AUM Growth
-$173M
(-8.7%)
Cap. Flow
-$12.6M
Cap. Flow
% of AUM
-0.69%
Top 10 Holdings %
Top 10 Hldgs %
21.66%
Holding
336
New
19
Increased
100
Reduced
123
Closed
17
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
$16.2M |
| 2 |
WSFS Financial
WSFS
|
$9.05M |
| 3 |
PayPal
PYPL
|
$1.75M |
| 4 |
ASML
ASML
|
$1.72M |
| 5 |
Danaher
DHR
|
$1.48M |
Top Sells
| 1 |
XLNX
Xilinx Inc
XLNX
|
$21.7M |
| 2 |
EPAY
Bottomline Technologies Inc
EPAY
|
$14.4M |
| 3 |
BMTC
Bryn Mawr Bank Corp
BMTC
|
$10M |
| 4 |
Apple
AAPL
|
$1.6M |
| 5 |
Charles Schwab
SCHW
|
$1.21M |
Sector Composition
| 1 | Technology | 27.66% |
| 2 | Healthcare | 14.39% |
| 3 | Financials | 13% |
| 4 | Industrials | 8.61% |
| 5 | Consumer Discretionary | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
W.W. Grainger
GWW
$49.2B
| $1.04M | 0.06% |
2,010
| – | – |
|
152
Exelixis
EXEL
$10.1B
| $1.01M | 0.06% |
44,500
| – | – |
|
153
Goldman Sachs
GS
$227B
| $1M | 0.06% |
3,035
| – | – |
|
154
Weyerhaeuser
WY
$18.4B
| $997K | 0.06% |
26,319
| – | – |
|
155
Henry Schein
HSIC
$8.22B
| $973K | 0.05% |
11,163
| – | – |
|
156
Accenture
ACN
$158B
| $957K | 0.05% |
2,837
+54
| +2% | +$18.2K |
|
157
Merck
MRK
$210B
| $941K | 0.05% |
11,471
-12
| -0.1% | -$984 |
|
158
Incyte
INCY
$16.7B
| $901K | 0.05% |
11,350
| – | – |
|
159
Humana
HUM
$37.5B
| $899K | 0.05% |
2,065
| – | – |
|
160
Universal Display
OLED
$6.88B
| $841K | 0.05% |
5,035
+35
| +0.7% | +$5.85K |
|
161
Bristol-Myers Squibb
BMY
$95B
| $835K | 0.05% |
11,430
-32
| -0.3% | -$2.34K |
|
162
US Bancorp
USB
$76.5B
| $796K | 0.04% |
14,973
-66
| -0.4% | -$3.51K |
|
163
Wells Fargo
WFC
$262B
| $793K | 0.04% |
16,373
+50
| +0.3% | +$2.42K |
|
164
GE Aerospace
GE
$299B
| $758K | 0.04% |
13,293
-68
| -0.5% | -$3.88K |
|
165
SPDR S&P Bank ETF
KBE
$1.63B
| $738K | 0.04% |
14,092
-50
| -0.4% | -$2.62K |
|
166
IBM
IBM
$230B
| $736K | 0.04% |
5,659
+209
| +4% | +$27.2K |
|
167
Avanos Medical
AVNS
$587M
| $728K | 0.04% |
21,722
| – | – |
|
168
Schwab US Dividend Equity ETF
SCHD
$71.9B
| $719K | 0.04% |
27,348
-6,066
| -18% | -$159K |
|
169
iShares MSCI EAFE ETF
EFA
$65.9B
| $709K | 0.04% |
9,627
-1,280
| -12% | -$94.3K |
|
170
Vanguard FTSE Developed Markets ETF
VEA
$170B
| $699K | 0.04% |
14,551
+1,313
| +10% | +$63.1K |
|
171
Franklin Resources
BEN
$13.4B
| $667K | 0.04% |
23,881
-150
| -0.6% | -$4.19K |
|
172
Zimmer Biomet
ZBH
$20.8B
| $643K | 0.04% |
5,029
-724
| -13% | -$92.6K |
|
173
WisdomTree US Total Dividend Fund
DTD
$1.44B
| $610K | 0.03% |
+9,454
| New | +$610K |
|
174
Medtronic
MDT
$119B
| $603K | 0.03% |
5,436
+53
| +1% | +$5.88K |
|
175
EPAM Systems
EPAM
$9.36B
| $593K | 0.03% |
2,000
| – | – |
|